视网膜光凝联合玻璃体切除术治疗增生性糖尿病视网膜病变的有效性及安全性

doi:10.6040/j.issn.1673-3770.0.2015.203

摘要/Abstract

摘要： 目的探讨视网膜光凝(RP)联合玻璃体切除术治疗增生性糖尿病视网膜病变(PDR)的有效性及安全性.方法回顾性分析2010年3月至2014年3月行RP联合玻璃体切除术的79例(79眼)PDR患者的临床资料,观察患者术后视力改善及手术并发症情况.结果术后随访12个月,视力提高61眼(77.22%),视力不变15眼(18.99%),下降3眼(3.80%).玻璃体切除术后1个月内有2眼发生眼压升高超过30 mmHg,1眼出现新生血管性青光眼(NVG)、1眼出现视网膜脱离; 3个月内有2例出现玻璃体再出血; 12个月内有2眼发生硅油乳化继发青光眼.结论玻璃体切除术后造影能够有效治疗RP,既能避免过度光凝,又能防止光凝不足,在提高患者视力的同时,可减少并发症,提高安全性,值得临床推广.

关键词: 视网膜病变, 玻璃体切除术, 视网膜光凝术, 并发症

Abstract: Objective To investigate the effectiveness and safety of retinal photocoagulation(RP) in combination with vitrectomy in treatment of proliferative diabetic retinopathy(PDR). Methods The clinical data of 79 patients (79 eyes) with PDR treated by RP and vitrectomy in our hospital during March 2010 to March 2014 were retrospectively analyzed. Results In a follow-up of 12 months after the operation, 61 eyes (77.22%) improved their post-operative visual acuity, 15 eyes (18.99%) had the same vision and 3 eyes (3.80%) had deterioration. After vitrectomy of 1 month, 2 eyes had the iop elevated over 30 mmHg, 1 eye had neovascular glaucoma (NVG), and 1 eye had retinal detachment. After vitrectomy of 3 months, 2 eyes had fro vitreous hemorrhage again. After vitrectomy of 12 months, 2 eyes had silicone oil emulsification occurred secondary glaucoma. Conclusion Angiography after vitrectomy can be targeted to treat RP. It can avoid excessive photocoagulation and can prevent photocoagulation insufficiently, improves in vision at the same time with few complications and high safety, is an effective method for PDR.

Key words: Vitrectomy, Retinopathy, Complications, Retinal photocoagulation

中图分类号:

R774.1

胡新苗. 视网膜光凝联合玻璃体切除术治疗增生性糖尿病视网膜病变的有效性及安全性[J]. 山东大学耳鼻喉眼学报, 2015, 29(6): 74-77.

HU Xinmiao. Effectiveness and safety of retinal photocoagulation in combination with vitrectomy for proliferative diabetic retinopathy[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2015, 29(6): 74-77.

参考文献

[1] 梅锋,周琼.增殖性糖尿病视网膜病变的玻璃体切除术的疗效分析[J].中国现代医学杂志,2012,22(18):107-109. MEI Feng, ZHOU Qiong. Effect analysis of the vitrectomy for the treatment of proliferative diabetic retinopathy[J]. Chin J Mod Med, 2012, 22(18):107-109.
[2] 刘玉梅,颜华.玻璃体切割术治疗玻璃体积血临床疗效观察[J].天津医药,2011,39(6):574-575. LIU Yumei, YAN Hua. Clinical effect of vitrectomy for vitreous hemorrhage[J]. Tianjin Med J, 2011, 39(6):574-575.
[3] 杜新华,吴强,宋蓓雯,等.非外伤性玻璃体积血的发病原因及疗效分析[J].眼科新进展,2013,33(1):44-47. DU Xinhua, WU Qiang, SONG Beiwen, et al. Etiopathogenisis and curative effects of none-traumatic vitreous hemorrhage[J]. Recent Adv Ophthalmol, 2013, 33(1):44-47.
[4] 张萃丽,张明媚,陈雪艺,等.玻璃体积血的病因分析及手术治疗的疗效[J].国际眼科杂志,2014(4):711-713. ZHANG Cuili, ZHANG Mingmei, CHEN Xueyi, et al. Analysis on the causes of vitreous hemorrhage and effects of surgical treatment[J]. Inter J Ophthalmol, 2014(4):711-713.
[5] 王雨生,田超伟,苏晓娜,等.玻璃体切割手术治疗息肉状脉络膜血管病变引起的玻璃体积血的疗效观察[J].中华眼底病杂志,2013,29(2):159-161. WANG Yusheng, TIAN Chaowei, SU Xiaona, et al. Efficacy of vitrectomy for vitreous hemorrhage in patients with polypoidal choroidal vasculopathy[J]. Chin J Ocular Fundus Dis, 2013, 29(2):159-161.
[6] Witmer M T, Cohen S M. Oral anticoagulation and the risk of vitreous hemorrhage and retinal tears in eyes with acute posterior vitreous detachment[J]. Retina, 2013, 33(3):621-626.
[7] 王颖,江枫,韩金栋,等.玻璃体腔硅油或C3F8填充对增生型糖尿病视网膜病变并发单纯玻璃体积血玻璃体切割手术疗效的影响[J].中华眼底病杂志,2014,30(2):148-151. WANG Ying, JIANG Feng, HAN Jindong, et al. Effects of vitrectomy combined with intraocular silicon oil or C3F8 tamponade on vitreous hemorrhage due to proliferative diabetic retinopathy[J]. Chin J Ocular Fundus Dis, 2014, 30(2):148-151.
[8] 张先平,刘华.玻璃体切除硅油填充术后高眼压的临床治疗[J].临床眼科杂志,2012,20(1):43-45. ZHANG Xianping, LIU Hua. Clinical therapy of ocular hypertension after vitrectomy and silicone oil injection[J]. J Clin Ophthalmol, 2012, 20(1):43-45.
[9] 贾俊,何媛,刘慧峰,等.玻璃体切除联合视网膜光凝治疗增生性糖尿病视网膜病变[J].国际眼科杂志,2014,14(5):866-867. JIA Jun, HE Yuan, LIU Huifeng, et al. Treatment of proliferative diabetic retinopathy by vitrectomy combined with retinal photocoagulation[J]. Inter J Ophthalmol, 2014, 14(5):866-867.
[10] 张竖,姜士军,蒋燕玲,等.周边视网膜光凝治疗中度非增殖期糖尿病视网膜病变的临床疗效观察[J].中华眼科医学杂志:电子版,2015,5(1):27-29. ZHANG Shu, JIANG Shijun, JIANG Yanling, et al. Efficacy of laser photocoagulation in the treatment ofmoderate non-proliferative diabetic retinopathy[J]. Chin J Ophthalmol Med Electr Ed, 2015, 5(1):27-29.

相关文章 15

[1]	赵娟,焦万珍,赵博军. UWFSS-OCTA检测糖尿病视网膜病变微循环的变化[J]. 山东大学耳鼻喉眼学报, 2026, 40(2): 80-86.
[2]	孙庆祝,沈健,陈星,吴雁冰,曾论. 代谢指标在预测糖尿病性黄斑水肿患者雷珠单抗疗效中的作用[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 74-81.
[3]	卢朝阳, 翟兆雪, 王慧康, 邵丽婷, 张宇. 新冠肺炎治疗引发糖尿病酮症酸中毒合并鼻眶脑型毛霉菌病1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 90-94.
[4]	朱云龙,王平,高萌. 误诊为中浆及视网膜炎的后巩膜炎1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 99-105.
[5]	高琳,何金梅,杨明祎. 糖尿病视网膜病变患者血清Sestrin2和NADPH氧化酶2水平与眼底病变的相关性[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 113-117.
[6]	宋艳玲,司元元,崔彦. 微量玻璃体切除治疗激光笔致儿童全层黄斑裂孔1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 144-147.
[7]	王焕霞,王淑雅,王影,孙璇,黄杰,王兴荣. 孔源性视网膜脱离玻璃体切除术后继发黄斑前膜的危险因素分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 181-185.
[8]	马馨,董凌康,吴红敏,易红良,邹建银. 外展悬吊缝合技术在阻塞性睡眠呼吸暂停治疗中的改良及应用进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(3): 81-88.
[9]	李致富,高玉. 玻璃体切除术后视野缺损的机制研究及预防[J]. 山东大学耳鼻喉眼学报, 2025, 39(3): 168-176.
[10]	张国明,魏文斌,林浩添,迟玮,张少冲,赵培泉,雷柏英,陈有信,王雨生,何明光,梁建宏,卢海,陆方,黄欣,梁小玲,赵欣予,吴桢泉,余震,崔凯璇,刘亚玲,项道满,陈长征,张自峰,林铎儒,于珊珊,孙悦,檀韬,陈燕先,彭婕,董力,程湧,朱雪梅,杨鹏,陈少滨. 人工智能技术辅助早产儿视网膜病变诊疗专家共识(2025)[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 1-5.
[11]	肖哲,张胜娟,赵子琦,兴辰,李成泉,刘志强. Ultra Q:YAG激光治疗黄斑部视网膜前出血17例并文献复习[J]. 山东大学耳鼻喉眼学报, 2025, 39(1): 130-135.
[12]	杨淞月,张美霞. 单细胞RNA测序技术在视网膜中的研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(1): 162-170.
[13]	辛梦,纪芳,代春华,张靖,刘澍. 医用透明质酸钠与平衡盐溶液在微创玻璃体手术中对眼表保护的影响[J]. 山东大学耳鼻喉眼学报, 2024, 38(5): 58-65.
[14]	马莉,高瞻,李鹏起,倪前伟. 鼻眶筛并发颧骨骨折伴发症解剖研究现状[J]. 山东大学耳鼻喉眼学报, 2024, 38(5): 126-130.
[15]	李浩,杨丽媛,张守凯. 鼻窦药物缓释支架在难治性鼻窦炎中的短期临床观察[J]. 山东大学耳鼻喉眼学报, 2024, 38(3): 38-42.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed